Jihua Tian

626 total citations
37 papers, 419 citations indexed

About

Jihua Tian is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jihua Tian has authored 37 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Nephrology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jihua Tian's work include Renal Diseases and Glomerulopathies (7 papers), Renal cell carcinoma treatment (5 papers) and Inflammasome and immune disorders (5 papers). Jihua Tian is often cited by papers focused on Renal Diseases and Glomerulopathies (7 papers), Renal cell carcinoma treatment (5 papers) and Inflammasome and immune disorders (5 papers). Jihua Tian collaborates with scholars based in China and United States. Jihua Tian's co-authors include Rongshan Li, Yanhong Wang, Xiaoshuang Zhou, Xing Zeng, Zhiquan Hu, Weiping Fan, Jing Kang, Ruijing Zhang, Xi Qiao and Le Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Experimental Biology and Medicine.

In The Last Decade

Jihua Tian

37 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jihua Tian China 13 217 78 76 61 50 37 419
Kefei Wu China 13 176 0.8× 74 0.9× 75 1.0× 50 0.8× 57 1.1× 26 471
Zena Huang China 12 360 1.7× 109 1.4× 63 0.8× 46 0.8× 73 1.5× 26 621
Xueting Hu China 8 118 0.5× 59 0.8× 61 0.8× 72 1.2× 26 0.5× 13 344
Linghao Wang China 11 217 1.0× 38 0.5× 51 0.7× 54 0.9× 71 1.4× 25 389
Jin-Ho Kang South Korea 14 258 1.2× 54 0.7× 91 1.2× 112 1.8× 60 1.2× 26 629
Haibin Sun China 12 183 0.8× 28 0.4× 79 1.0× 38 0.6× 36 0.7× 25 376
Quan‐you Zheng China 12 122 0.6× 58 0.7× 121 1.6× 28 0.5× 26 0.5× 21 360

Countries citing papers authored by Jihua Tian

Since Specialization
Citations

This map shows the geographic impact of Jihua Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jihua Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jihua Tian more than expected).

Fields of papers citing papers by Jihua Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jihua Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jihua Tian. The network helps show where Jihua Tian may publish in the future.

Co-authorship network of co-authors of Jihua Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Jihua Tian. A scholar is included among the top collaborators of Jihua Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jihua Tian. Jihua Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Jihua, Huanyu Xu, Zhijie Ma, et al.. (2025). Extracellular vesicles delivered rapamycin to improve the tumor microenvironment and enhance hepatocellular carcinoma immunotherapy. European Journal of Pharmaceutics and Biopharmaceutics. 211. 114714–114714. 1 indexed citations
2.
3.
Tian, Jihua, Jing Luo, Xing Zeng, et al.. (2024). Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 12(2). e008226–e008226. 12 indexed citations
4.
Tian, Jihua, et al.. (2023). Cytoreductive partial and radical nephrectomies provide equivalent oncologic outcomes in T1–2M1 renal cell carcinoma. Translational Cancer Research. 12(2). 301–309. 5 indexed citations
5.
Chen, Zhi, Ke Chen, Le Li, et al.. (2023). Non‐SMC condensin I complex subunit H participates in anti‐programmed cell death‐1 resistance of clear cell renal cell carcinomas. Cell Proliferation. 56(7). e13400–e13400. 16 indexed citations
6.
Tian, Jihua, Xing Zeng, Jie Wan, et al.. (2022). Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study. Frontiers in Oncology. 11. 819098–819098. 4 indexed citations
7.
Zeng, Xing, Ke Chen, Le Li, et al.. (2022). Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11. Free Radical Biology and Medicine. 184. 135–147. 46 indexed citations
8.
Tian, Jihua, et al.. (2021). The p70S6K/PI3K/MAPK feedback loop releases the inhibition effect of high-dose rapamycin on rat mesangial cell proliferation. International Journal of Immunopathology and Pharmacology. 35. 3938471136–3938471136. 4 indexed citations
9.
Liu, Qingqing, Yongbo Kang, Yan Tian, et al.. (2021). Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability. The Journal of Nutritional Biochemistry. 98. 108863–108863. 60 indexed citations
10.
Tian, Jihua, et al.. (2021). Role of sphingosine-1-phosphate mediated signalling in systemic lupus erythematosus. Prostaglandins & Other Lipid Mediators. 156. 106584–106584. 7 indexed citations
11.
Tian, Jihua, Li Zhang, Min Hu, et al.. (2021). Heterotopic Ossification of the Inferior Vena Cava Wall: A Case Report and Literature Review. Frontiers in Surgery. 8. 738934–738934. 1 indexed citations
12.
Hu, Zhiquan, et al.. (2020). Application of Tumor Markers in Patients with Urachal Carcinoma. SHILAP Revista de lepidopterología. 2 indexed citations
13.
Wang, Yanhong, Zhi-Jing Wu, Jihua Tian, et al.. (2019). Intermedin protects HUVECs from ischemia reperfusion injury via Wnt/β-catenin signaling pathway. Renal Failure. 41(1). 159–166. 10 indexed citations
14.
Qin, Fuzhong, Andréia Biolo, Cao Gao, et al.. (2018). Glutaredoxin 1 overexpression inhibits JNK activity and ameliorates myocyte apoptosis and progression to heart failure in Galphaq overexpressing transgenic mice. Free Radical Biology and Medicine. 128. S38–S38. 1 indexed citations
15.
Wang, Yanhong, et al.. (2015). Intermedin ameliorates IgA nephropathy by inhibition of oxidative stress and inflammation. Clinical and Experimental Medicine. 16(2). 183–192. 16 indexed citations
16.
Tian, Jihua, et al.. (2015). The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option. Experimental and Molecular Pathology. 99(3). 435–440. 18 indexed citations
17.
Wang, Yanhong, Jihua Tian, Xi Qiao, et al.. (2015). Intermedin protects against renal ischemia-reperfusion injury by inhibiting endoplasmic reticulum stress. BMC Nephrology. 16(1). 169–169. 37 indexed citations
18.
Tian, Jihua, Yanhong Wang, Xiaoshuang Zhou, et al.. (2014). Rapamycin Slows IgA Nephropathy Progression in the Rat. American Journal of Nephrology. 39(3). 218–229. 17 indexed citations
19.
Tian, Jihua, Yanhong Wang, Xinyan Liu, Xiaoshuang Zhou, & Rongshan Li. (2014). Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms. Experimental Biology and Medicine. 240(7). 936–945. 18 indexed citations
20.
Tian, Jihua, et al.. (2012). Time-Frequency Analysis Based Motor Fault Detection Using Deconvolutive STFT Spectrogram. Journal of Convergence Information Technology. 7(8). 295–300. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kefei Wu Breakdown of academic impact, for papers by Zena Huang Breakdown of academic impact, for papers by Xueting Hu Breakdown of academic impact, for papers by Linghao Wang Breakdown of academic impact, for papers by Jin-Ho Kang Breakdown of academic impact, for papers by Haibin Sun Breakdown of academic impact, for papers by Quan‐you Zheng
Rankless by CCL
2026